On the other hand, brain-derived neurotrophic factor (BDNF) and neurotrophin-4/5 bind to TrkB and atypical activation of TrkB due to mutations or fusions involving NTRK2 can contribute to oncogenic transformation in certain cancers. The gene discussed is NTRK2; the disease is cancer.